0.85ml Ophthalmic Surgery Sodium Hyaluronate For Glaucoma

Sodium Hyaluronate for Ophthalmic Surgery

Sodium Hyaluronate for Ophthalmic Surgery is a highly viscous transparent liquid prepared by the method of biological fermentation of sodium hyaluronate, which has similar permeability, ion concentration and pH value to human aqueous humor. The product applies to cataract extraction, intraocular lens implantation and removal surgery and ocular surgery and other ophthalmic surgery to maintain the depth of the anterior chamber and surgical instruments, coat surgical instruments and plays an important in protecting corneal endothelial cells from mechanical damage.

The sodium Hyaluronate Ophthalmic Solution Indication:

The Sodium Hyaluronate Ophthalmic Solution is ophthlmic viscoelastic gel, used for:

• Intraocular lens extraction and implantation
• Cornel transplantation
• Glaucoma operation
• Retinal detachment
• Eye injury and ophthalmic surgery

The sodium Hyaluronate Ophthalmic Solution Characteristics:

• Colorless, transparent, uniform and isotonic gel.

• No pyrogen, no antiger, no sensitive and allergic reaction.

• High viscosity, elasticity and pseudo plasticity.

• Better adhesion and spreading ability, protect corneal andothelial cells effectively.

• Easy cleaning after the operation.

Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. was founded in 1991, is one of the first enterprises in China to produce intraocular lenses and related products. It has introduced advanced American technology and established a complete automated production line, integrating R&D, production, and sales. After 30 years of development, it has become China A benchmark enterprise in the field of intraocular lenses.

Till now, our company has products in sale, such as PMMA Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma Drainage Implants, Hydroxypropyl Methylcellulose, Sodium Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in 1991, with very low incidences of adverse effects and serious adverse events.

The highest eminence is to be gianed step by step.  Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. will work hard and innovate constantly to improve the quantity of products, elevate the core competitiveness of the enterprise and make even greater contribution to the human health undertaking.